|
Melanie Bruno provides executive leadership and direction to position Kendle's Regulatory Affairs brand as a global market leader. In this capacity, she leads teams of specialists with global expertise in regulatory consulting and submissions, pharmacovigilance/safety, medical writing and clinical quality assurance.
Having worked previously at Eli Lilly and Company and Procter & Gamble Pharmaceuticals, Dr. Bruno specializes in providing strategic regulatory guidance on development projects for new prescription and marketed products. She currently serves on the Board of Editors for Regulatory Affairs Focus, the professional journal of the Regulatory Affairs Professional Society. | 